LCMT1
Basic information
Region (hg38): 16:25111731-25178231
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LCMT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 13 | 1 | 1 |
Variants in LCMT1
This is a list of pathogenic ClinVar variants found in the LCMT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-25111909-C-A | not specified | Uncertain significance (Aug 19, 2024) | ||
16-25111915-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
16-25111918-C-T | not specified | Uncertain significance (Mar 05, 2024) | ||
16-25111950-G-T | not specified | Uncertain significance (Aug 02, 2022) | ||
16-25128480-C-T | not specified | Uncertain significance (Sep 10, 2024) | ||
16-25128509-T-C | not specified | Uncertain significance (Dec 14, 2023) | ||
16-25132411-C-T | not specified | Uncertain significance (Sep 22, 2023) | ||
16-25132414-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
16-25132453-G-A | not specified | Uncertain significance (Jul 30, 2024) | ||
16-25140204-G-A | not specified | Uncertain significance (Jul 14, 2024) | ||
16-25140213-C-A | not specified | Uncertain significance (Dec 16, 2021) | ||
16-25140216-A-G | not specified | Uncertain significance (Apr 08, 2024) | ||
16-25140226-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
16-25140239-C-G | not specified | Uncertain significance (May 30, 2024) | ||
16-25161138-T-C | not specified | Uncertain significance (Mar 20, 2024) | ||
16-25161210-AT-A | Benign (Jun 15, 2018) | |||
16-25164713-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
16-25169128-G-T | not specified | Uncertain significance (Jul 20, 2021) | ||
16-25169163-C-A | not specified | Uncertain significance (Mar 13, 2023) | ||
16-25169163-C-T | not specified | Uncertain significance (Feb 17, 2023) | ||
16-25170756-G-T | not specified | Uncertain significance (Feb 28, 2023) | ||
16-25170759-G-A | not specified | Uncertain significance (Sep 18, 2024) | ||
16-25170790-G-A | not specified | Uncertain significance (May 05, 2023) | ||
16-25174990-G-A | not specified | Likely benign (Aug 02, 2021) | ||
16-25175023-G-A | not specified | Uncertain significance (May 13, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LCMT1 | protein_coding | protein_coding | ENST00000399069 | 11 | 66503 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000179 | 0.973 | 124625 | 0 | 28 | 124653 | 0.000112 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.628 | 160 | 184 | 0.870 | 0.00000965 | 2181 |
Missense in Polyphen | 36 | 56.115 | 0.64154 | 700 | ||
Synonymous | -0.0607 | 70 | 69.4 | 1.01 | 0.00000375 | 617 |
Loss of Function | 2.01 | 11 | 20.9 | 0.526 | 0.00000110 | 241 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000470 | 0.000397 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000168 | 0.000167 |
Finnish | 0.000105 | 0.0000928 |
European (Non-Finnish) | 0.0000621 | 0.0000619 |
Middle Eastern | 0.000168 | 0.000167 |
South Asian | 0.000232 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Methylates the carboxyl group of the C-terminal leucine residue of protein phosphatase 2A catalytic subunits to form alpha-leucine ester residues. {ECO:0000269|PubMed:10600115}.;
- Pathway
- Cyclin A/B1/B2 associated events during G2/M transition;G2/M Transition;Mitotic G2-G2/M phases;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- loftool
- 0.785
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.09
Haploinsufficiency Scores
- pHI
- 0.0224
- hipred
- Y
- hipred_score
- 0.669
- ghis
- 0.568
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.908
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lcmt1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); renal/urinary system phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- G2/M transition of mitotic cell cycle;cellular protein modification process;protein methylation;C-terminal protein methylation;regulation of glucose metabolic process;negative regulation of protein complex assembly;regulation of apoptotic process;regulation of mitotic cell cycle spindle assembly checkpoint
- Cellular component
- nucleoplasm;cytosol
- Molecular function
- protein C-terminal carboxyl O-methyltransferase activity;protein binding;S-adenosylmethionine-dependent methyltransferase activity;protein C-terminal leucine carboxyl O-methyltransferase activity